retatrutide triple hormone receptor agonist retatrutide Original Article: Triple–Hormone-Receptor for Obesity — A Phase 2 Trial https://t.co/jNL1GNnHPT #ADA23 A phase 2 clinical trial

Ideal for men and women looking for a practical and delicious way to care for their skin, hair and overall health

This results in the potential for numerous serious health concerns to arise

Rates of patients switching from AOM tirzepatide declined in the months following July 2025 and returned to near baseline levels by October, and growth in AOM tirzepatide prescribing rebounded after the initial decline

Preclinical studies in rodents have identified a potential association between GLP-1 receptor agonists and thyroid C-cell tumours, though there is no confirmed causal link established in humans to date

[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Shaw K.A., Maenner M.J., Bakian A.V., Bilder D.A., Durkin M.S., Furnier S.M., Hughes M.M., Patrick M., Pierce K., Salinas A., et al